TY - JOUR AU - Chatwal, Monica S. AU - Tanvetyanon, Tawee PY - 2018 TI - Combination chemotherapy and immunotherapy in metastatic non-small cell lung cancer: a setback for personalized medicine? JF - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1 Y2 - 2018 KW - N2 - The management landscape for metastatic non-small cell lung cancer (NSCLC) has changed considerably beyond chemotherapy alone. This is due to the introduction of targeted therapies for patients with targetable mutations and the advent of immune checkpoint inhibitors. UR - https://tlcr.amegroups.org/article/view/23127